Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells

PLoS One. 2017 Oct 12;12(10):e0186035. doi: 10.1371/journal.pone.0186035. eCollection 2017.

Abstract

Several attempts have been made to model chronic myeloid leukemia (CML) in a xenograft setting but expansion of human myeloid cells in immunodeficient mice has proven difficult to achieve. Lack of cross-reacting cytokines in the microenvironment of the mice has been proposed as a potential reason. In this study we have used NOD/SCID IL2-receptor gamma deficient mice expressing human SCF, IL-3 and GM-CSF (NSGS mice), that should be superior in supporting human, and particularly, myeloid cell engraftment, to expand BCR-ABL1 expressing human cells in order to model CML. NSGS mice transplanted with BCR-ABL1 expressing cells became anemic and had to be sacrificed due to illness, however, this was not accompanied by an expansion of human myeloid cells but rather we observed a massive expansion of human T-cells and macrophages/histiocytes. Importantly, control human cells without BCR-ABL1 expression elicited a similar reaction, although with a slight delay of disease induction, suggesting that while BCR-ABL1 contributes to the inflammatory reaction, the presence of normal human hematopoietic cells is detrimental for NSGS mice.

MeSH terms

  • Animals
  • Cytokines / genetics*
  • Disease Models, Animal
  • Female
  • Fetal Blood / cytology*
  • Fetal Blood / transplantation
  • Fusion Proteins, bcr-abl / genetics*
  • Gene Expression
  • Granulocyte-Macrophage Colony-Stimulating Factor / genetics
  • Humans
  • Interleukin-3 / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
  • Male
  • Mice, Inbred NOD
  • Mice, SCID
  • Mice, Transgenic
  • Transduction, Genetic
  • Transplantation, Heterologous

Substances

  • BCR-ABL1 fusion protein, human
  • Cytokines
  • IL3 protein, human
  • Interleukin-3
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Fusion Proteins, bcr-abl

Grants and funding

This work was supported by the Swedish Cancer Society (project no. 2014/430) (TF); Swedish Research Council (project no 2016/02020) (TF); and Swedish Cancer Society CAN 2012/1253 (MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.